Federal Trade Commission
FTC’s Legal Pas de Deux: A Pause in the Amgen-Horizon Acquisition
Anika Sharma
In the world of corporate clashes and strategic maneuvers, a legal ballet is unfolding, with the Federal Trade Commission (FTC) ...
Amgen challenges FTC’s bid to block $28B Horizon deal
Anika Sharma
Amid the ongoing legal battle with the Federal Trade Commission (FTC) over its $28 billion acquisition of Horizon Therapeutics, Amgen ...
Enhanced Merger Standards by FTC and DOJ Signal Heightened Scrutiny of M&A Transactions
SG Tylor
As the Federal Trade Commission (FTC) closely examines two significant biopharma mergers, both the FTC and the Department of Justice ...
